Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CUTERA INC | 77,216 | reported | 13 Feb 2025 | tx 15+337,500−112,784 |
| Lineage Cell Therapeutics, Inc. | 43,995 | reported | 18 Dec 2018 | tx 8+173,750−55,515 |
| Celladon Corp | 17,948 | reported | 12 Mar 2021 | tx 6+239,945 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2025 | TAX_WITHHOLDING | CUTERA INC | 623 | 0.42 USD | |
| 13 Nov 2024 | TAX_WITHHOLDING | CUTERA INC | 2,161 | 0.36 USD | |
| 24 Oct 2024 | GRANT_AWARD | CUTERA INC | 37,500 | 0.00 USD | deriv |
| 15 Jul 2024 | OTHER | CUTERA INC | 55,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | CUTERA INC | 30,000 | 0.00 USD | deriv |
| 15 Jul 2024 | OTHER | CUTERA INC | 30,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | CUTERA INC | 25,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | CUTERA INC | 55,000 | 0.00 USD | deriv |
| 15 Jul 2024 | OTHER | CUTERA INC | 25,000 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | CUTERA INC | 55,000 | 0.00 USD | deriv |
| 06 Mar 2024 | GRANT_AWARD | CUTERA INC | 30,000 | 0.00 USD | |
| 06 Mar 2024 | GRANT_AWARD | CUTERA INC | 25,000 | 0.00 USD | |
| 06 Mar 2024 | GRANT_AWARD | CUTERA INC | 25,000 | 0.00 USD | |
| 06 Mar 2024 | GRANT_AWARD | CUTERA INC | 30,000 | 0.00 USD | deriv |
| 06 Mar 2024 | GRANT_AWARD | CUTERA INC | 25,000 | 0.00 USD | deriv |
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 11,875 | 0.00 USD | |
| 12 Mar 2021 | GRANT_AWARD | Celladon Corp | 71,250 | 0.00 USD | deriv |
| 05 Mar 2020 | GRANT_AWARD | Celladon Corp | 820 | 7.31 USD | |
| 12 Mar 2020 | GRANT_AWARD | Celladon Corp | 65,000 | 0.00 USD | deriv |
| 22 Apr 2019 | PURCHASE | Celladon Corp | 1,000 | 11.03 USD | first after silence |
| 21 Mar 2019 | GRANT_AWARD | Celladon Corp | 90,000 | 0.00 USD | deriv |
| 18 Dec 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 27,500 | 0.00 USD | |
| 18 Dec 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 9,510 | 1.03 USD | |
| 18 Dec 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 27,500 | 0.00 USD | deriv |
| 04 Oct 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 4,755 | 2.22 USD |
1 purchase reported after at least 12 months of silence — most recent on 22 Apr 2019.